(NYSE: PRGO) Perrigo Co's forecast annual revenue growth rate of 0.64% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Perrigo Co's revenue in 2026 is $4,144,900,000.On average, 6 Wall Street analysts forecast PRGO's revenue for 2026 to be $574,643,443,545, with the lowest PRGO revenue forecast at $551,052,671,895, and the highest PRGO revenue forecast at $593,654,830,110. On average, 6 Wall Street analysts forecast PRGO's revenue for 2027 to be $578,806,520,895, with the lowest PRGO revenue forecast at $547,305,902,280, and the highest PRGO revenue forecast at $602,258,523,300.
In 2028, PRGO is forecast to generate $586,993,906,350 in revenue, with the lowest revenue forecast at $551,746,518,120 and the highest revenue forecast at $614,331,447,615.